APLT — Applied Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $463.78m
- $413.63m
- $9.99m
Annual cashflow statement for Applied Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -45.5 | -94 | -106 | -82.5 | -120 |
| Non-Cash Items | 6 | 11 | 15.9 | 13.7 | 66.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.21 | 4.8 | -1.02 | -9.29 | -1.81 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -36.3 | -78.2 | -90.7 | -78.1 | -55.2 |
| Other Investing Cash Flow Items | -20 | -19.5 | 12.4 | 13.2 | 13.9 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -20 | -19.5 | 12.4 | 13.2 | 13.9 |
| Financing Cash Flow Items | 16 | 2.52 | 4.43 | 3.1 | 1.55 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 56.4 | 136 | 74.7 | 27.7 | 74.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.102 | 38.6 | -3.58 | -37.2 | 33.2 |